| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.051 | 0.3 |